Here’s a quick recap on the state-level psychedelics bills under discussion -besides Colorado’s measure regulating the state’s implementation framework- as of May 2:
-
Arizona: HB 2489 or “The PTSD Treatment Act of 2023,” stating “any compound, mixture or preparation” containing MDMA that is both FDA-approved and DEA-down scheduled for the treatment of PTSD may be lawfully prescribed in the state, silently went over to the Governor’s desk, where it was finally approved on April 28.
-
California: Sen. Wiener’s SB 58 legalizing possession, preparation, obtaining and transferring of specific amounts (ranging from 2-15 grams) of natural psychedelics for personal and facilitated use of the substances cleared the Appropriations Committee and is now heading to the Senate floor under an accelerated process skipping further committee consideration, first reported Marijuana Moment.
-
Minnesota: HF1884, finally included in large-scale omnibus health bill HF 2930 in an amended version that creates a task force to address state law reform toward legalizing and regulating psychedelics medicine (namely psilocybin, MDMA and LSD) passed the state’s House floor and is now expected to move to a bicameral conference committee.
-
Missouri: HB 1154 toward state research on psilocybin for depression, PTSD, substance use disorders and end-of-life care went through several passes, amendments, laid overs, and is now back on the House’s Formal Perfection Calendar as of April 25.
-
Photo: Benzinga edit with photo by Alexander_Volkov and canbedone on Shutterstock.
-
ICYM Benzinga’s Psychedelics Capital Conference 2023
Here's some EXCLUSIVE coverage from the event’s second edition:
-
MDMA Therapy Experts Debate Upcoming Approval, Psychedelic Market Opps
-
Ketamine Therapy Leaders Share Bold Vision For Future Of Psychedelics
-
In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
-
Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits
-
Making The World A Better Place, How Psychedelics Are Helping
-
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.